Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pfizer
Pfizer
Covid-19: Pfizer to Seek Clearance in September for Vaccinating Children as Young as 2
NY Times, NY
Wed, 05/5/21 - 11:03 am
COVID-19
FDA
vaccines
Pfizer
BioNTech
pediatric
Pfizer plans to file for full FDA approval of Covid vaccine at the end of this month
CNBC
Tue, 05/4/21 - 10:56 pm
Pfizer
BioNTech
vaccines
COVID-19
FDA
Prevnar 13 lags amid COVID-19 vaccine rollouts, but Pfizer sees a way to boost the franchise
Fierce Pharma
Tue, 05/4/21 - 10:38 pm
Pfizer
vaccines
Prevnar 13
pneumococcal disease
Pfizer eyes $26B in COVID-19 vaccine sales for the year, with $3.5B already in the bag
Fierce Pharma
Tue, 05/4/21 - 10:54 am
Pfizer
COVID-19
vaccines
Pfizer halts BCMA trial amid safety woes, hit by DMD delay
Fierce Biotech
Tue, 05/4/21 - 10:53 am
Pfizer
BCMA
clinical trials
Duchenne Muscular Dystrophy
elranatamab
fordadistrogene movaparvovec
Pfizer beats earnings expectations and lifts guidance, as COVID-19 revenue outlook increases 73%
Marketwatch
Tue, 05/4/21 - 10:41 am
Pfizer
earnings
Pfizer COVID vaccine under EMA review for younger teens
RAPS.org
Mon, 05/3/21 - 10:57 pm
Pfizer
vaccines
COVID-19
EMA
Europe
Moderna Just Made the Pfizer Vaccine's Biggest Weakness an Even Bigger One
Motley Fool
Sun, 05/2/21 - 10:11 pm
Pfizer
Moderna Therapeutics
COVID-19
vaccines
The Pfizer CEO Prediction That Could Mean Total COVID Market Dominance in 2022
Motley Fool
Sat, 05/1/21 - 09:31 pm
Pfizer
COVID-19
BioNTech
vaccines
protease inhibitors
Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU
Yahoo/Reuters
Fri, 04/30/21 - 10:31 am
Pfizer
BioNTech
vaccines
Europe
COVID-19
pediatric
Biopharma Companies Wrestle with Staffing Situations and Shortages from Pandemic
BioSpace
Thu, 04/29/21 - 10:45 pm
COVID-19
pandemic
Sanofi
Pfizer
Moderna Therapeutics
Novartis
Lonza
Pfizer weighs sale of Philly-area campus—where 2,000 once worked—as company mulls when and how to bring employees back
Fierce Pharma
Wed, 04/28/21 - 09:53 pm
Pfizer
Philadelphia
Pfizer buys Amplyx to grow infectious disease pipeline
Fierce Biotech
Wed, 04/28/21 - 10:53 am
Pfizer
M&A
Amplyx
infectious diseases
Top U.S. trade negotiator meets Pfizer, AstraZeneca execs on COVID-19 IP waiver
Reuters
Tue, 04/27/21 - 11:29 pm
Pfizer
AstraZeneca
COVID-19
intellectual property
The retreat of corporate venture funding?
EP Vantage
Fri, 04/23/21 - 11:02 am
funding
venture funding
venture capital
AbbVie
Amgen
Boehringer Ingelheim
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Merck KGaA
Pfizer
Roche
Sanofi
Takeda
Pfizer and BioNTech Vaccine Sales Jump $1.4 Billion Thanks to AstraZeneca's Blunders
Motley Fool
Thu, 04/22/21 - 10:44 am
Pfizer
BioNTech
Europe
AstraZeneca
vaccines
COVID-19
A top analyst sees Pfizer and Moderna seizing a $38B prize as safety frets sideline global vaccine players
Endpoints
Tue, 04/20/21 - 11:10 am
Pfizer
Moderna Therapeutics
COVID-19
vaccines
JNJ
AstraZeneca
South African variant may 'break through' Pfizer vaccine protection, but vaccine highly effective, Israeli study says
Yahoo/Reuters
Sun, 04/18/21 - 11:35 pm
COVID-19
Pfizer
vaccines
BioNTech
COVID-19 variants
Pfizer CEO: Third COVID-19 Vaccine Dose Will Likely Be Needed Within 12 Months
BioSpace
Fri, 04/16/21 - 09:59 am
Pfizer
vaccines
COVID-19
Albert Bourla
Pharma CEOs
Johnson & Johnson asked rival COVID-19 vaccine makers to probe clotting risks
Yahoo/Reuters
Fri, 04/16/21 - 09:47 am
JNJ
Pfizer
BioNTech
Moderna Therapeutics
blood clots
vaccines
COVID-19
Pages
« first
‹ previous
…
56
57
58
59
60
61
62
63
64
…
next ›
last »